Back to Search Start Over

Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al.

Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al.

Authors :
Francis, Serene
Block, Joel A.
Hetland, Merete Lund
Linde, Louise
Christensen, Ib Jarle
Dreyer, Lene
Tarp, Ulrik
Hansen, Annette
Hansen, Ib Tønder
Kollerup, Gina
Lindegaard, Hanne M.
Poulsen, Uta Engling
Schlemmer, Annette
Jensen, Dorte Vendelbo
Jensen, Signe
Hostenkamp, Gisela
Østergaard, Mikkel
Source :
Arthritis & Rheumatism; Sep2010, Vol. 62 Issue 9, p2826-2828, 3p
Publication Year :
2010

Abstract

A letter to the editor is presented in response to the article "Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis Treated With Adalimumab, Etanercept, or Infliximab: Results From Eight Years of Surveillance of Clinical Practice in the Nationwide Danish DANBIO Registry," by Hetland et al in a 2010 issue.

Details

Language :
English
ISSN :
00043591
Volume :
62
Issue :
9
Database :
Complementary Index
Journal :
Arthritis & Rheumatism
Publication Type :
Academic Journal
Accession number :
54314591
Full Text :
https://doi.org/10.1002/art.27606